Affimed Ord Shs (NQ: AFMD )
3.980
+0.030
(+0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Affimed Ord Shs
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3659.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
Analyst Ratings for Affimed
December 12, 2022
Via Benzinga
4 Analysts Have This to Say About Affimed
December 12, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709928/dna-genetic-sequencing-biotech.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
From Affimed N.V.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
From Affimed N.V.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image44.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/logo_light__b6f2b03faea1d55bebb92e6e45e9bd8a_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image17.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image45.jpg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
From Affimed N.V.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/12/12/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/12/12/logo_light__b6f2b03faea1d55bebb92e6e45e9bd8a.png?width=1200&height=800&fit=crop)
Citing Lack Of Durability, Affimed Scraps AFM13 Monotherapy Plans For NK Cell Combo
December 12, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image_3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/image26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image-target_corporation_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/16/image-lowes_companies.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/c293ce9b-e9d6-4729-ad95-f3ddf01f3791/small/affimed-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9843.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/08/image16.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.